Merck's trial of KEYTRUDA regimen fails to meet primary endpoint

Retrieved on: 2024-05-10 17:15:12

Tags for this article:

Click the tags to see associated articles and topics

Merck's trial of KEYTRUDA regimen fails to meet primary endpoint. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Merck & Co Inc.

Article found on: www.clinicaltrialsarena.com